Locations:
Search
But findings apply only to middle-aged or older men with confirmed hypogonadism
Findings hold implications for screening and potential nonsurgical therapy
Potential benefits include clinical guidance, TAVR outcome prediction, device testing
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Sophisticated in vivo modeling can enhance device development and therapy testing
DT-MRI and RNA-FISH show increase in CITED4 promotes healthy architecture of myocardium
Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up
First report of major endpoint reduction in patients with biopsy-proven NASH
TMAO pathway impacts infarct size and functional impairment in preclinical stroke models
Cleveland Clinic-led study supports investigation of similar immunomodulatory therapies
Advertisement
Advertisement